Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Filings indexed 396 across all filing types
Latest filing 2024-12-16 Notice of Dividend Amou…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 1% confidence The document is a short regulatory announcement from Cellumed regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 40th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal regulatory notice of a corporate action (setting a record date). Given it is a standard regulatory disclosure regarding meeting preparation, it fits best under the RNS category.
2024-12-16 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '셀루메드' (Cellumed) covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, business operations, management discussions, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
증권발행결과(자율공시) (제29회차 CB)
Capital/Financing Update Classification · 1% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a private placement of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2024-11-12 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market. Since it details the terms, purpose, and issuance of debt instruments, it falls under the 'Capital/Financing Update' category.
2024-11-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding collateral loan extensions for the company Cellumed by its major shareholder, Inscobee. This falls under the category of major shareholding notifications.
2024-11-05 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, including the reporting of major shareholding thresholds and changes in special relationships. This falls under the 'Major Shareholding Notification' category.
2024-11-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.